Literature DB >> 23568760

Asparagine deamidation dependence on buffer type, pH, and temperature.

Amanda L Pace1, Rita L Wong1, Yonghua Taylor Zhang2, Yung-Hsiang Kao2, Y John Wang3.   

Abstract

The deamidation of asparagine into aspartate and isoaspartate moieties is a major pathway for the chemical degradation of monoclonal antibodies (mAbs). It can affect the shelf life of a therapeutic antibody that is not formulated or stored appropriately. A new approach to detect deamidation using ion exchange chromatography was developed that separates papain-digested mAbs into Fc and Fab fragments. From this, deamidation rates of each fragment can be calculated. To generate kinetic parameters useful in setting shelf life, buffers prepared at room temperature and then placed at the appropriate stability temperatures. Solution pH was not adjusted to the same at different temperatures. Deamidation rate at 40°C was faster in acidic buffers than in basic buffers. However, this trend is reversed at 5°C, attributed to the change in hydroxide ion concentration influenced by buffer and temperature. The apparent activation energy was higher for rates generated in an acidic buffer than in a basic buffer. The rate-pH profile for mAb1 can be deconvoluted to Fc and Fab. The Fc deamidation showed a V-shaped profile: deamidation of PENNY peptide is responsible for the rate at high-pH, whereas deamidation of a new site, Asn323, may be responsible for the rate at low-pH. The profile for Fab is a straight line without curvature.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568760     DOI: 10.1002/jps.23529

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

1.  Antibody characterization using novel ERLIC-MS/MS-based peptide mapping.

Authors:  Jing Zhen; John Kim; Ying Zhou; Ervinas Gaidamauskas; Shyamsundar Subramanian; Ping Feng
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

2.  Engineering deamidation-susceptible asparagines leads to improved stability to thermal cycling in a lipase.

Authors:  K Bhanuramanand; Shoeb Ahmad; N M Rao
Journal:  Protein Sci       Date:  2014-08-05       Impact factor: 6.725

3.  Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry.

Authors:  Sara Rosati; Yang Yang; Arjan Barendregt; Albert J R Heck
Journal:  Nat Protoc       Date:  2014-03-27       Impact factor: 13.491

4.  A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization.

Authors:  Yan An; Ying Zhang; Hans-Martin Mueller; Mohammed Shameem; Xiaoyu Chen
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

5.  Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.

Authors:  Qi Wang; Elise E Drouin; Chunxiang Yao; Jiyang Zhang; Yu Huang; Deborah R Leon; Allen C Steere; Catherine E Costello
Journal:  J Proteome Res       Date:  2016-11-07       Impact factor: 4.466

6.  Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics.

Authors:  Sahithi Ravuluri; Rohit Bansal; Nidhi Chhabra; Anurag S Rathore
Journal:  Pharm Res       Date:  2018-05-14       Impact factor: 4.200

Review 7.  Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.

Authors:  Kerry M Wooding; Wenjing Peng; Yehia Mechref
Journal:  Curr Pharm Biotechnol       Date:  2016       Impact factor: 2.837

8.  Rapid Highly-Efficient Digestion and Peptide Mapping of Adeno-Associated Viruses.

Authors:  Estee Naggar Toole; Craig Dufresne; Somak Ray; Alexander Schwann; Ken Cook; Alexander R Ivanov
Journal:  Anal Chem       Date:  2021-07-22       Impact factor: 6.986

9.  Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab.

Authors:  Tao Liu; Jin Xu; Qingcheng Guo; Dapeng Zhang; Jun Li; Weizhu Qian; Huaizu Guo; Xinli Zhou; Sheng Hou
Journal:  Front Chem       Date:  2022-04-05       Impact factor: 5.545

10.  Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods.

Authors:  Heesu Chae; Seulki Cho; Munsik Jeong; Kiyoung Kwon; Dongwook Choi; Jaeyoung Lee; Woosuk Nam; Jisu Hong; Jiwoo Lee; Seonjoo Yoon; Hyojeong Hong
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.